Notably, many cancers exhibit increased LDLR expression and activity, LDL uptake, and upregulated cholesterol synthesis and esterification, as well as loss of fundamental homeostatic control of cholesterol metabolism whereby the negative feedback relationship between de novo synthesis and uptake via LDLR is dysregulated [6, 7]. This evidence concerns the gene LDLR and cancer.